title: On the prohibition of conflicts of interest in pharmaceutical regulation: precautionary limits and permissive challenges. A commentary on Sismondo (66:9, 2008, 1909-14) and O'Donovan and Lexchin.
authors.affiliation: School of Social Sciences, University of Sussex, Arts E Building Falmer, Brighton BN19QN, United Kingdom. j.w.abraham@sussex.ac.uk
authors.forename: John
authors.initials: J
authors.lastname: Abraham
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics; D016265:Conflict of Interest; D003659:Decision Making, Organizational; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D004335:Drug and Narcotic Control / Q000458:organization & administration*; D006077:Government Agencies / Q000458:organization & administration*; D033161:Government Regulation; D006801:Humans